PRESS RELEASE Leading generics maker is usually recognized for excellent growth.
PRESS RELEASE Leading generics maker is usually recognized for excellent growth. Bridgewater, NJ , October 21, 2014 – Amneal Pharmaceuticals LLC is very happy to announce that the business has gained the global Company of the Year – Americas Award from Generics bulletin, a newsletter which provides commercial and regulatory details for the global biosimilars and generics industries http://synthroid100mcg.net/doses-and-side-effects.html . Presented on October 7 at the Global Generics & Biosimilars Awards 2014 kept in Paris, France, the award recognizes Amneal’s rapid growth in THE UNITED STATES.
Amgen therapeutics have transformed the practice of medicine, helping thousands of people all over the world in the fight against cancer, kidney disease, arthritis rheumatoid and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to significantly improve people’s lives. For more information about our pioneering research and our vital medications, visit.. Amgen’s First Quarter 2008 Adjusted Earnings Per Talk about Increased 4 % to $1.12 Amgen reported adjusted earnings per talk about , excluding stock choice expense and certain other expenses, of $1.12 for the first quarter of 2008, a rise of 4 % in comparison to $1.08 for the first one fourth of 2007.